The drug, Aimovig, made by Amgen and Novartis, is a monthly injection with a device similar to an insulin pen. Aimovig blocks a protein fragment, CGRP, that instigates and perpetuates migraines
from Health https://ift.tt/2KQP9Eq
Thursday, May 24, 2018
Thursday, May 24, 2018
MZ Digital Marketing Agency
HEALTH NEWS
No comments
Related Posts:
LATEST HEALTH NEWSA U.S. court has granted Indivior a preliminary injunction blocking India's Dr. Reddy's Laboratories from selling cut-price versions of the British drugmaker's best-selling opioid addiction treatment in the United States, Ind… Read More
LATEST HEALTH NEWSChina's new medical insurance regulator will begin negotiations with domestic and overseas pharmaceutical companies to lower prices of cancer drugs in a bid to cut the financial burden on patients, state news agency Xinhua sa… Read More
LATEST HEALTH NEWSThe Iowa and Illinois health departments said on Thursday that they were investigating cyclospora infections linked to salads at McDonald Corp's restaurants. from Reuters: Health News https://ift.tt/2mblWcS … Read More
LATEST HEALTH NEWSScientists studying the effects of the potentially game-changing gene editing tool CRISPR/Cas9 have found it can cause unexpected genetic damage which could lead to dangerous changes in some cells. from Reuters: Health N… Read More
LATEST HEALTH NEWSIndivior Plc's shares jumped more than 33 percent on Monday after a U.S. court blocked a rival from selling a cheaper copycat of the British drugmaker's bestselling opioid addiction treatment. from Reuters: Health News h… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment